A sharp surge in the number of diabetes patients, 77 million and counting, has turned India into a hotspot for deals to buy or sell prestigious medicine brands to treat the chronic disease. In the latest move, the USD60 billion drug giant Merck, known as MSD in India, has decided to put its iconic anti-diabetes brands Januvia and Janumet on the block, several industry executives tell ET Prime. The key patents for the drug granted in India
An Indian nurse (L) collects a blood sample from a policeman using a glucometer at a free diabetic health check-up camp on World Health Day in Hyderabad on April 7, 2016. Synopsis India nurses the second highest number of diabetics in the world. For most diabetics, fighting the slow-killer disease involves sticking to pills for […]
“When I started practice in India about 30 years ago, I would see a person under 30 years or between 30 and 35 years with some heart trouble only once or twice in a year. Now I see them every week.” This statement from India’s renowned heart surgeon Ramakant Panda reveals a disturbing reality of […]
Sudhir Srivastava (centre) with his expanding team at SS Innovations; image credit: SS Innovations Synopsis In an exclusive interaction with ET Prime, cardiac surgeon Sudhir Prem Srivastava, the man behind 1,500 successful robotic surgeries, discusses his eventful journey. He details the concept, design and instrumentation of five-armed Mantra, the robotic surgery system, and the dire […]